Andrew Levin, MD, PhD, is co-founder and Director of Clear Creek Bio. He is a Managing Director of RA Capital where he leads the firm's new company formation efforts. He is a builder (Legos, molecules, companies). He has become a prolific inventor, motivated by tackling real world medical problems.
Andrew was previously Vice President at H.I.G. BioVentures and before that Director of Pharmaceutical Sciences at the Clinton Health Access Initiative. He holds a BSE in mechanical engineering from Princeton University, a PhD in biomedical engineering from the Massachusetts Institute of Technology, and an MD from the Harvard-MIT Division of Health Sciences and Technology.